<DOC>
	<DOCNO>NCT01552291</DOCNO>
	<brief_summary>Malnutrition occur 50 % patient require elective surgery neoplastic disease . It exert detrimental influence outcome surgery , suppress immune function , exaggerate stress response cause organ system dysfunction . Increased susceptibility infection , protract wound healing , impair blood clot vessel wall fragility show leading cause postoperative morbidity mortality malnourish patient undergo major surgical resection . This trial design prospective randomize , double-blinded , placebo-controlled pilot study academic single center Switzerland . A total 50 malnourish patient gastro-intestinal tumor receive orally glutamine placebo-treatment period 5 day prior surgery . The investigator hypothesize oral Glutamine administration feasible , well tolerate , decrease postoperative morbidity , suppress postoperative cell damage inflammatory response , improve perioperative immunocompetence patient .</brief_summary>
	<brief_title>The Impact Preoperative Oral Glutamine Intake Immunocompetence Outcomes Malnourished Patients Undergoing Major Abdominal Surgery Due Malignancies</brief_title>
	<detailed_description>Background Malnutrition occur 50 % patient require elective surgery neoplastic disease . It exert detrimental influence outcome surgery , suppress immune function , exaggerate stress response cause organ system dysfunction . Increased susceptibility infection , protract wound healing , impair blood clot vessel wall fragility show leading cause postoperative morbidity mortality malnourish patient undergo major surgical resection . Immuno- pharmaconutrition , define enteral parenteral nutritional therapy base variety product , omega-3-fatty acid , glutamine , arginine , sulfur-containing amino acid , nucleotide anti-oxidants , think beneficial effect postoperative recovery wide variety surgical patient . Studies show clinical effectiveness term reduce postoperative complication , shorten hospital stay reduce hospitalization cost . Torosian et al . show severely malnourished patient benefit preoperative nutrition , reduce postoperative complication 20 % . Although clinical evidence administration immunonutrition patient perioperative period , understand optimal type time immunonutrition , characteristic patient benefit , well immunological mechanism responsible beneficial effect limit . Objective To assess malnourished cancer patient effect 30g oral glutamine/day ( 3 sachet KABI® glutamine , Fresenius Kabi/day ) preoperative course 5 day : 1 . Postoperative morbidity ( surgical site infection , pneumonia , sepsis , incidence wind fascial dehiscence , incisional hernia , anastomotic break ) 2 . Nutritional status patient 3 . Postoperative cell damage inflammatory response 4 . Perioperative immunocompetence Methods Seven day surgery , patient receive tetanus booster shot randomly enrol either 'glutamine group ' 'placebo group ' . The patient well responsible surgeon blind . - Patients 'glutamine group ' receive 30g oral glutamine / day 5 day surgery . - Patients 'control group ' receive 30g oral maltodextrin / day 5 day surgery .</detailed_description>
	<mesh_term>Malnutrition</mesh_term>
	<mesh_term>Digestive System Neoplasms</mesh_term>
	<mesh_term>Gastrointestinal Neoplasms</mesh_term>
	<criteria>Histologically confirm surgically resectable carcinoma Candidates elective surgery estimate surgical stress score A Nutritional Risk Screening 2002 ( NRS200232 ) score ≥3 Age ≥ 18 year Completed primary immunization tetanus toxoid Last tetanus booster ≥10 year back Informed consent Exclusion Criteria Refusal participate Clinically relevant alteration pulmonary renal hepatic function Insulindependent diabetes mellitus Preexisting autoimmune disease immunedeficiencies Neutropenia Pregnancy Age &lt; 18 year Last tetanus booster &lt; 10 year back Ongoing infection Intestinal obstruction time entry study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Malnourishment</keyword>
	<keyword>Gastrointestinal tumor</keyword>
	<keyword>Immunocompetence</keyword>
</DOC>